Referencias bibliográficas del artículo:

Referencias

1. Harjes LM, Parker VJ, Dembek K, et al. Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease. J Vet Intern Med. 2017; 31: 784-790.
2. Marino CL, Lascelles BDX, Vaden SL, et al. Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies. J Feline Med Surg 2014;16: 465-472. 
3. O’Neill D.G, Elliott J, Church D.B, et al. Chronic kidney disease in dogs in UK veterinary practices: prevalence, risk factors, and survival. J Vet Intern Med. 2013; 27:814–821. 
4. Egenvall A, Bonnett B.N, Haggstrom J, et al. Morbidity of insured Swedish cats during 1999-2006 by age, breed, sex, and diagnosis. J Feline Med Surg. 2010; 12: 948–959.
5. Boyd L.M, Langston C, Thompson K, et al. Survival in cats with naturally occurring chronic kidney disease (2000-2002). J Vet Intern Med. 2008; 22:1111–1117.
6. Segev G, Cortellini S, Foster JD, et al. International Renal Interest Society best practice consensus guidelines for the diagnosis and management of acute kidney injury in cats and dogs. Vet J. 2024; 305:106068
7. Rudinsky A.J, Harjes L.M, Byron J, et al. Factors associated with survival in dogs with chronic kidney disease. J Vet Intern Med. 2018; 32: 1977–1982.
8. www.iris-kidney.com.Último acceso 6/7/2024.
9. Craig AJ, Seguela J, Queau Y et al. Redefining the Reference Interval for Plasma Creatinine in Dogs: Effect of Age, Gender, Body Weight, and Breed. J Vet Inter Med 2006: 20; 3: 740.
10.  Reynolds BS, Germain C, Boudet K et al. Breed-dependency of basal plasma creatinine: a cat is not a cat. J Vet Inter Med 2008: 22; 3: 797.
11. Hall JA, Yerramilli M, Obare E, et al. Relationship between lean body mass and serum renal biomarkers in healthy dogs. J Vet Intern Med 2015; 29: 808-814
12. Sargent HJ, Elliott J, Jepson RE. The new age of renal biomarkers: does SDMA solve all of our problems? J Small Anim Pract. 2021; 62: 71-81.
13. Paltrinieri S, Giraldi M, Prolo A, et al. Serum symmetric dimethylarginine and creatinine in Birman cats compared with cats of other breeds. J Feline Med Surg 2018; 20: 905-912.  
14. Liffman R, Johnstone T, Tennent-Brown B, et al. Establishment of reference intervals for serum symmetric dimethylarginine in adult nonracing Greyhounds. Vet Clin Pathol. 2018; 47: 458-463.
15. Cortadellas O, Fernández del Palacio MJ, Talavera J, et al. Glomerular filtration rate in dogs with leishmaniasis and chronic kidney disease. J Vet Intern Med. 2008; 22: 293-300.
16. Segev G, Vaden S, Ross S, et al. Urinary cystatin B differentiates progressive versus stable IRIS Stage 1 chronic kidney disease in dogs. J Vet Intern Med.2023; 37:2251-2260.
17. Geddes RF, Elliott J, Syme HM. Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Survival Time in Cats with Chronic Kidney Disease. J Vet Intern Med. 2015; 29: 1494-1501.
18. Cortadellas O, Fernández del Palacio MJ, Talavera J, et al. Calcium and phosphorus homeostasis in dogs with spontaneous chronic kidney disease at different stages of severity. J Vet Intern Med. 2010; 24: 73-79
19. Grelová S, Karasová M, Tóthová C, et al. Relationship between FGF 23, SDMA, Urea, Creatinine and Phosphate in Relation to Feline Chronic Kidney Disease. Animals (Basel). 2022 Aug 31;12(17):2247
20. Geddes RF, Elliott J, Syme HM. Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Survival Time in Cats with Chronic Kidney Disease. J Vet Intern Med 2015; 29: 1494-1501.
21. Lapsina S, Nagler N, Müller SF, et al. Fibroblast Growth Factor-23 (FGF-23) in Dogs-Reference Interval and Correlation with Hematological and Biochemical Parameters. Animals (Basel). 2023 Oct 13;13(20):3202.